C1-Inhibitor substitution as ultima ratio therapy in septic shock: experience with 15 patients
B Vangerow, Gernot Marx, Martin Leuwer, Horst Rueckoldt · Critical Care · 1998
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Critical Care · BioMed Central · conference-abstract · 1998
Abstract
Plasma C1-Inhibitor (C1-INH) is the major inhibitor of both the classical pathway of complement system and contact activation. A relative deficiency of C1-INH has been proposed as an important contributor to the development of shock and organ failure [ 1 , 2 ]. Among others, our working group has published two cases of successful C1-INH substitution in septic patients recently [ 3 ].
Open the resolved locator · 10.1186/cc149
Metadata licence: OpenAlex metadata (CC0)